Yemima Berman

ORCID: 0000-0003-2495-4928
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neurofibromatosis and Schwannoma Cases
  • Genetics and Physical Performance
  • Soft tissue tumor case studies
  • Sports Performance and Training
  • BRCA gene mutations in cancer
  • Genomics and Rare Diseases
  • Soft tissue tumors and treatment
  • Muscle metabolism and nutrition
  • Genomic variations and chromosomal abnormalities
  • Cardiomyopathy and Myosin Studies
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Effects of Exercise
  • CRISPR and Genetic Engineering
  • Meningioma and schwannoma management
  • Vascular Malformations Diagnosis and Treatment
  • Dupuytren's Contracture and Treatments
  • RNA Research and Splicing
  • Prion Diseases and Protein Misfolding
  • Intestinal and Peritoneal Adhesions
  • Ophthalmology and Visual Impairment Studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Vascular Malformations and Hemangiomas
  • Cystic Fibrosis Research Advances
  • Hallucinations in medical conditions
  • Ocular Disorders and Treatments

Royal North Shore Hospital
2011-2025

The University of Sydney
2010-2025

Northern Sydney Local Health District
2021-2024

Massachusetts General Hospital
2021

Masonic Cancer Center
2021

University of Minnesota
2021

North Shore Hospital
2021

Children's Hospital at Westmead
2007-2017

Tirat Carmel Mental Health Center
2013

Center for Human Genetics
2007

Eric Legius Ludwine Messiaen P. Wolkenstein Patrice Pancza Robert A. Avery and 87 more Yemima Berman Jaishri O. Blakeley Dusica Babovic‐Vuksanovic Karin Soares Cunha Rosalie E. Ferner Michael J. Fisher Jan M. Friedman David H. Gutmann Hildegard Kehrer‐Sawatzki Bruce R. Korf Victor‐Felix Mautner Sirkku Peltonen Katherine A. Rauen Vincent M. Riccardi Elizabeth K. Schorry Anat Stemmer‐Rachamimov David A. Stevenson Gianluca Tadini Nicole J. Ullrich David Viskochil Katharina Wimmer Kaleb Yohay Alicia Gomes Justin T. Jordan Victor Mautner Vanessa L. Merker Miriam J. Smith David A. Stevenson Monique Anten Arthur S. Aylsworth Diana Baralle S. Barbarot Fred G. Barker Shay Ben‐Shachar Amanda Bergner D. Bessis Ignacio Blanco Cathérine Cassiman Patricia Ciavarelli Maurizio Clementi Thierry Frébourg Marco Giovannini Dorothy Halliday Chris Hammond C. Oliver Hanemann Helen Hanson Arvid Heiberg K.H. Ly Michel Kalamarides Matthias A. Karajannis Daniela Kroshinsky Margarita Larralde Conxi Lázaro Lu Q. Le Michael P. Link Robert Listernick Mia MacCollin Conor Mallucci Christopher L. Moertel Amy Mueller Joanne Ngeow Rianne Oostenbrink Roger J. Packer Laura Papi Allyson Parry Juha Peltonen Dominique C. Pichard Bruce Poppe Nilton Alves de Rezende Luiz Oswaldo Carneiro Rodrigues Tena Rosser Martino Ruggieri Eduard Serra Verena Steinke‐Lange Stavros Stivaros Amy Taylor Jaan Toelen James H. Tonsgard Eva Trevisson Meena Upadhyaya Ali Varan Meredith Wilson Hao Wu Gelareh Zadeh Susan Huson D. Gareth Evans Scott R. Plotkin

PurposeBy incorporating major developments in genetics, ophthalmology, dermatology, and neuroimaging, to revise the diagnostic criteria for neurofibromatosis type 1 (NF1) establish Legius syndrome (LGSS).MethodsWe used a multistep process, beginning with Delphi method involving global experts subsequently non-NF experts, patients, foundations/patient advocacy groups.ResultsWe reached consensus on minimal clinical genetic diagnosing differentiating NF1 LGSS, which have phenotypic overlap...

10.1038/s41436-021-01170-5 article EN cc-by Genetics in Medicine 2021-06-04
Adam Bournazos Lisa G. Riley Shobhana Bommireddipalli Lesley C. Adès Lauren Akesson and 95 more Mohammad Al-Shinnag Stephen I. Alexander Alison D. Archibald Shanti Balasubramaniam Yemima Berman Victoria Beshay Kirsten Boggs Jasmina Bojadzieva Natasha J. Brown Samantha J. Bryen Michael F. Buckley Belinda Chong Mark R. Davis Ruebena Dawes Martin B. Delatycki Liz Donaldson Lilian Downie Matthew Edwards Matthew Edwards Amanda Engel Lisa Ewans Fathimath Faiz Andrew Fennell Michael Field Mary‐Louise Freckmann Lyndon Gallacher Russell Gear Himanshu Goel Shuxiang Goh Linda Goodwin Bernadette Hanna James Harraway Megan Higgins Gladys Ho Bruce Hopper Ari Horton Matthew F. Hunter Aamira Huq Sarah Josephi‐Taylor Himanshu Joshi Edwin P. Kirk Emma Krzesinski Kishore R. Kumar Frances A. Lemckert Richard J. Leventer Suzanna Lindsey-Temple Sebastian Lunke Alan Ma Steven Macaskill Amali Mallawaarachchi Melanie A. Marty Justine E. Marum Hugh J. McCarthy Manoj P. Menezes Alison McLean Di Milnes Shekeeb S. Mohammad David Mowat Aram Niaz Elizabeth E. Palmer Chirag Patel Chirag Patel Dean Phelan Jason Pinner Sulekha Rajagopalan Matthew Regan Jonathan Rodgers Miriam Rodrigues Richard Roxburgh Rani Sachdev Tony Roscioli Ruvishani Samarasekera Sarah A. Sandaradura Elena Savva Tim Schindler Margit Shah Ingrid Sinnerbrink Janine Smith Richard J. Smith Amanda Springer Zornitza Stark Samuel P. Strom Carolyn M. Sue Kenneth Tan Tiong Yang Tan Esther Tantsis Michel Tchan Bryony A. Thompson Alison H. Trainer Karin van Spaendonck‐Zwarts Rebecca Walsh Linda Warwick Stephanie White Susan M. White Mark Williams

10.1016/j.gim.2021.09.001 article EN Genetics in Medicine 2021-11-30

The complications of neurofibromatosis type 1 (NF1) are widespread, unpredictable and variable each person's experience this disorder is unique. However, few studies have addressed the impact NF1 from an individual's perspective. This qualitative study aims to identify ways in which impacts upon affected Australian adults. Sixty adults with NF1, a range disease severity visibility participated semi-structured interview about impacted their life health. Data were analyzed using grounded...

10.1007/s10897-015-9829-5 article EN Journal of Genetic Counseling 2015-04-17

Identifying and targeting established modifiable risk factors has been a successful strategy for reducing the burden of coronary artery disease (CAD) at population-level. However, up to 1-in-4 patients who present with ST elevation myocardial infarction do so in absence such factors. Polygenic scores (PRS) have demonstrated an ability improve prediction models independent traditional self-reported family history, but pathway implementation yet be clearly identified. The aim this study is...

10.1016/j.ahj.2023.06.009 article EN cc-by-nc-nd American Heart Journal 2023-06-25

Lissencephaly is a neuronal migration disorder leading to absent or reduced gyration and broadened but poorly organized cortex. The most common form of lissencephaly isolated, referred as classic type 1 lissencephaly. Type mostly associated with heterozygous deletion the entire LIS1 gene, whereas intragenic mutations hemizygous DCX in males are less common.Eighteen unrelated patients were clinically genetically assessed. In addition, subcortical band heterotopia (n = 1) cerebellar hypoplasia...

10.1212/01.wnl.0000266629.98503.d0 article EN Neurology 2007-07-30

Abstract The skin manifestations of neurofibromatosis 1 significantly reduce health‐related quality‐of‐life. However, data on the utility existing surveys in capturing treatment outcomes are lacking. This quantitative study examined relationship between clinician‐rated severity and visibility patient‐rated itch quality‐of‐life (QoL) to (1) establish baseline levels skin‐ condition‐specific‐related QoL, itch, depression anxiety; (2) identify patient concerns inform development evaluation...

10.1111/1346-8138.17276 article EN cc-by The Journal of Dermatology 2024-06-24

Abstract Background Neurofibromatosis 1 (NF1) is a common cancer predisposition syndrome. Affected individuals require lifelong surveillance and often suffer progressive disfigurement due to cutaneous neurofibromas. The aim of this research was characterize health concerns quality life (QOL) in population cohort. Methods An online survey completed by 68 adults 32 parents children with NF1, 60 controls. included the Skindex‐29 QOL scale, 5D‐itch additional questions. Results Frequency itch...

10.1002/mgg3.2077 article EN cc-by Molecular Genetics & Genomic Medicine 2022-11-28

In order to explore the use of Skindex scoring in patients with neurofibromatosis type 1 (NF1) across multiple clinical sites and inform design additional quality life measures, we analyzed correlations between Skindex, site, measures for 79 NF1 from specialized clinics Sydney, Australia (Royal North Shore Hospital [RNS]) Minneapolis, Minnesota (University [UMN]).The relationship factors scores were explored by clinic site overall.A total 40 participants recruited RNS 39 UMN. Female sex,...

10.1212/wnl.0000000000012427 article EN Neurology 2021-07-06

Genomic testing for a genetic diagnosis is becoming standard of care many children, especially those with syndromal intellectual disability. While previously this type specialised was performed mainly by clinical genetics teams, it increasingly being 'mainstreamed' into paediatric care. With the introduction new Medicare rebate genomic in May 2020, now available paediatricians to order, consultation genetics. Children must be aged less than 10 years facial dysmorphism and multiple congenital...

10.1111/jpc.15382 article EN cc-by Journal of Paediatrics and Child Health 2021-02-10

A bstract Purpose: To characterize the ophthalmic features and causes of visual loss in a cohort Melanesians living New Caledonia with nanophthalmos. Methods: In this observational study, axial length, acuity (VA), cycloplegic autorefraction were assessed dilated fundus examination was performed. Visual impairment defined as VA < 6/12 better eye, hypermetropia >+1.0 dioptre (D), astigmatism ≥1.0 D anisometropia difference between both eyes. Unilateral amblyopia at least two‐line eyes...

10.1111/j.1442-9071.2007.01484.x article EN Clinical and Experimental Ophthalmology 2007-05-01

The neurofibromatoses, which include neurofibromatosis type I (NF1), II (NF2), and schwannomatosis, are a group of syndromes characterized by tumor growth in the nervous system. RASopathies caused germline mutations genes that encode components RAS/mitogen‐activated protein kinase (MAPK) pathway. NF1, Noonan syndrome, syndrome with multiple lentigines, Costello cardio‐facio‐cutaneous Legius capillary malformation arterio‐venous SYNGAP1 autism. Due to their common underlying pathogenetic...

10.1002/ajmg.a.61125 article EN American Journal of Medical Genetics Part A 2019-03-25

Lifelong health monitoring is recommended in neurofibromatosis type 1 ( NF1 ) because of the progressive and unpredictable range disabling potentially life‐threatening symptoms that arise. In Australia, strategies for surveillance are less well developed adults than they children, resulting inequalities between pediatric adult care. The aims this study were to determine uptake capacity with self‐manage their health. Australian n = 94, 18–40 years) participated a semi‐structured interview....

10.1111/cge.12627 article EN Clinical Genetics 2015-06-17

NSW Health is implementing genomics as a mainstream component of clinical care. The strategic, holistic approach considering infrastructure, data governance and management, workforce, education, service planning delivery. This work generating insights about how to realise the promise in healthcare, highlighting need for strong foundations, real-world application, accessibility focus on people using genomic information

10.1071/ah23112 article EN cc-by-nc-nd Australian Health Review 2023-10-16
Coming Soon ...